30 January 2024
COLEFAX GROUP PLC (“Colefax” or the “Group”) Half Year Results for the six months ended 31 October 2023 Colefax is an international designer and…
30 January 2024 Pressure Technologies plc (“Pressure Technologies” or “the Company” or “the Group”) 2023 Full-Year Results Pressure Technologies plc (AIM: PRES), the specialist engineering…
Wynnstay Group Plc (“Wynnstay” or the “Group” or the “Company”) Final Results For the year ended 31 October 2023 KEY POINTS Financial · Much softer…
Harworth Group plc (“Harworth” or “the Company”) Year-end Trading Update Management actions drive robust performance in 2023 and strong momentum into 2024 Harworth Group…
Diageo delivers strong cash generation and is well positioned for future growth despite challenging first half environment â—¦ Reported net sales of $11.0 billion…
30 January 2024 Accrol Group Holdings plc (“Accrol, the “Group” or the “Company”) HALF YEAR RESULTS Strong performance, with margins and volume continuing to…
29 January 2024
European Commission authorises GSK’s Omjjara (momelotinib) · Omjjara is the first medicine in the EU specifically indicated for treating splenomegaly (enlarged spleen) or symptoms in adult myelofibrosis patients with…
26 January 2024
The Conygar Investment Company PLC Director/PDMR Shareholding The Conygar Investment Company PLC (“Conygar” or “Company”), the property investment and development group, announces that it…